Micro-doses of Physical Activity for COPD

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorUniversity of British Columbia

About this trial

Chronic obstructive pulmonary disease (COPD) is a disease of the lungs that makes it hard for people to breath. Those with COPD spend considerably more time sitting and lying and less time performing physical activity than healthy individuals. Those who are the most sedentary have a greater risk of heart and blood vessel disease, which may lead to an early death. This project will investigate the effect of sitting still for 3 hours on blood vessel health in individuals with COPD. It will also investigate whether breaking up the amount of time patients sit with regular short bouts of walking (5 minutes each hour) at a comfortable pace chosen by the patient can have a positive effect on maintaining the health of their blood vessels. It is hypothesized that blood vessel health will be worse after 3 hours of sitting compared to when the sitting is broken up by short bouts of walking.

Eligibility criteria

Qualifiers

None

Disqualifiers

performing structured exercise training (or pulmonary rehabilitation)

have a history of deep vein thrombosis

are on anticoagulant medication

have advanced cardiac or cerebrovascular disease (i.e. heart failure, previous stroke or myocardial infarction)

Trial design

Treatments tested in this trial

  • Microdoses of activity

Treatment groups

20 Participants
are divided into 2 treatment groups

Sponsors and collaborators